Atlas Trials

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

Clinical trial NCT02169453 · COMPLETED

Trial details

NCT number
NCT02169453
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease (PD)
Start date
2008-10-01
Primary completion
2009-01-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.